Paul Paik

13PUBLICATIONS
113CO-AUTHORS
Molecular targetsNeurology and neuromuscular diseasesChemotherapyMedical biotechnology diagnostics (incl. biosensors)Cryptography
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 03, 2026
Resistance to Immune Checkpoint Inhibitor Treatment in Non-Small Cell Lung Cancer Clinical Trials: A Perspective From Lung-MAP Investigators.

|Dec 05, 2025
Presenting Features and Causes of Diagnostic Delays: A Report From the NUT Carcinoma Registry.

Sara A Walton, Justin J Kim, Francesco Paoloni

|Jul 24, 2025
Molecular Characterization of NUT Carcinoma: A Report from the NUT Carcinoma Registry.

Justin J Kim, Sara A Walton, Navin R Mahadevan

|Jul 11, 2025
Phase I Clinical Trial of the Bifunctional EGFR/TGF-β Fusion Protein Ficerafusp Alfa (BCA101) Alone and in Combination with Pembrolizumab for Advanced Solid Tumors.

Alberto Hernando-Calvo, Richard D Carvajal, Paul K Paik

|May 01, 2025
Liquid and Tissue Biopsies for Identifying MET Exon 14 Skipping NSCLC: Analyses from the Phase II VISION Study of Tepotinib.

Christian Rolfo, Aurora O'Brate, Christoph Menzel

|Jun 28, 2024
A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung Cancer.

Noura J Choudhury, W Victoria Lai, Alex Makhnin

Pageof 3

Frequent Collaborators

3 joint publications

Jia Luo

3 joint publications

Glenn J Hanna

2 joint publications

Sara A Walton

2 joint publications

Helena A Yu